• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌 细 胞 中 C/EBP-β 通过 Akt 通 路 对 miR-145 的 负 调 节。

Negative regulation of miR-145 by C/EBP-β through the Akt pathway in cancer cells.

机构信息

Department of Medical Microbiology, Immunology and Cell Biology, Southern Illinois University School of Medicine, Springfield, IL 62794, USA.

出版信息

Nucleic Acids Res. 2012 Aug;40(14):6683-92. doi: 10.1093/nar/gks324. Epub 2012 Apr 11.

DOI:10.1093/nar/gks324
PMID:22495929
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3413133/
Abstract

MicroRNAs are master gene regulators that can also be under the control of transcriptional regulation. We have previously shown that miR-145 is a tumor suppressor capable of silencing c-Myc and the tumor suppressor p53 induces miR-145 by directly binding to the miR-145 promoter, demonstrating the role of miR-145 in p53-mediated c-Myc repression. However, little is known as to why miR-145 is often downregulated in tumors. In this study, we identify CCAAT/enhancer binding protein beta (C/EBP-β) as a negative regulator for miR-145 expression by direct interaction with the putative C/EBP-β binding site in the miR-145 promoter. In the wild-type p53 background, C/EBP-β counteracts the ability of p53 to induce miR-145. Moreover, C/EBP-β is able to suppress miR-145 in the mutant p53 background, suggesting the p53 independent regulation of miR-145. Of interest, both the large isoform (LAP-2) and the small isoform (LIP) of C/EBP-β can exert suppressive function for miR-145. Finally, we further show that, like serum starvation and PI3K inhibitor LY29, the antioxidant resveratrol suppresses pAkt and phosphorylation of C/EBP-β and at the same time, it induces miR-145. Together, these results suggest a miR-145 regulatory system involving the Akt and C/EBP-β, which may contribute to the downregulation of miR-145 in cancer cells.

摘要

微小 RNA 是主基因调控因子,也可以受到转录调控的控制。我们之前已经表明,miR-145 是一种肿瘤抑制因子,能够沉默 c-Myc,肿瘤抑制因子 p53 通过直接结合 miR-145 启动子诱导 miR-145 的表达,证明了 miR-145 在 p53 介导的 c-Myc 抑制中的作用。然而,miR-145 在肿瘤中经常下调的原因知之甚少。在这项研究中,我们通过直接与 miR-145 启动子中的假定 C/EBP-β 结合位点相互作用,鉴定出 CCAAT/增强子结合蛋白 β(C/EBP-β)是 miR-145 表达的负调控因子。在野生型 p53 背景下,C/EBP-β 抵消了 p53 诱导 miR-145 的能力。此外,C/EBP-β 能够在突变型 p53 背景下抑制 miR-145,表明 miR-145 的 p53 独立调节。有趣的是,C/EBP-β 的大异构体(LAP-2)和小异构体(LIP)都可以发挥抑制 miR-145 的功能。最后,我们进一步表明,与血清饥饿和 PI3K 抑制剂 LY29 一样,抗氧化剂白藜芦醇抑制 pAkt 和 C/EBP-β 的磷酸化,同时诱导 miR-145。综上所述,这些结果表明存在涉及 Akt 和 C/EBP-β 的 miR-145 调节系统,这可能导致癌细胞中 miR-145 的下调。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b2b/3413133/9047b7ce7398/gks324f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b2b/3413133/0b210a911fd9/gks324f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b2b/3413133/1c7e2a93a311/gks324f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b2b/3413133/1c5463ed01c8/gks324f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b2b/3413133/557e8812f228/gks324f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b2b/3413133/97c397f76af7/gks324f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b2b/3413133/f06916763673/gks324f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b2b/3413133/9047b7ce7398/gks324f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b2b/3413133/0b210a911fd9/gks324f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b2b/3413133/1c7e2a93a311/gks324f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b2b/3413133/1c5463ed01c8/gks324f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b2b/3413133/557e8812f228/gks324f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b2b/3413133/97c397f76af7/gks324f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b2b/3413133/f06916763673/gks324f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b2b/3413133/9047b7ce7398/gks324f7.jpg

相似文献

1
Negative regulation of miR-145 by C/EBP-β through the Akt pathway in cancer cells.癌 细 胞 中 C/EBP-β 通过 Akt 通 路 对 miR-145 的 负 调 节。
Nucleic Acids Res. 2012 Aug;40(14):6683-92. doi: 10.1093/nar/gks324. Epub 2012 Apr 11.
2
p53 represses c-Myc through induction of the tumor suppressor miR-145.p53通过诱导肿瘤抑制因子miR-145来抑制c-Myc。
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3207-12. doi: 10.1073/pnas.0808042106. Epub 2009 Feb 6.
3
Transcription factor C/EBP-β induces tumor-suppressor phosphatase PHLPP2 through repression of the miR-17-92 cluster in differentiating AML cells.转录因子C/EBP-β通过抑制分化型急性髓系白血病细胞中的miR-17-92簇来诱导肿瘤抑制磷酸酶PHLPP2。
Cell Death Differ. 2016 Jul;23(7):1232-42. doi: 10.1038/cdd.2016.1. Epub 2016 Feb 12.
4
Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells.Stat3 和 CCAAT/增强子结合蛋白β(C/EBP-β)调节乳腺癌细胞中 Jab1/CSN5 的表达。
Breast Cancer Res. 2011 Jun 20;13(3):R65. doi: 10.1186/bcr2902.
5
VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma.VPS33B 通过与 NESG1 相互作用调节 EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p 信号通路并诱导鼻咽癌对 5-氟尿嘧啶的敏感性。
Cell Death Dis. 2019 Apr 3;10(4):305. doi: 10.1038/s41419-019-1457-9.
6
Resveratrol inhibited the progression of human hepatocellular carcinoma by inducing autophagy via regulating p53 and the phosphoinositide 3‑kinase/protein kinase B pathway.白藜芦醇通过调节 p53 和磷脂酰肌醇 3-激酶/蛋白激酶 B 通路诱导自噬来抑制人肝癌的进展。
Oncol Rep. 2018 Nov;40(5):2758-2765. doi: 10.3892/or.2018.6648. Epub 2018 Aug 17.
7
Autoregulation enables different pathways to control CCAAT/enhancer binding protein beta (C/EBP beta) transcription.自身调节使不同途径能够控制CCAAT/增强子结合蛋白β(C/EBPβ)的转录。
J Mol Biol. 2001 Jun 15;309(4):855-68. doi: 10.1006/jmbi.2001.4708.
8
Protein kinase C-dependent, CCAAT/enhancer-binding protein beta-mediated expression of insulin-like growth factor I gene.蛋白激酶C依赖性、CCAAT/增强子结合蛋白β介导的胰岛素样生长因子I基因表达。
J Biol Chem. 2002 May 3;277(18):15261-70. doi: 10.1074/jbc.M110827200. Epub 2002 Feb 1.
9
Histone deacetylase inhibitor prevents cell growth in Burkitt's lymphoma by regulating PI3K/Akt pathways and leads to upregulation of miR-143, miR-145, and miR-101.组蛋白去乙酰化酶抑制剂通过调节 PI3K/Akt 通路抑制伯基特淋巴瘤细胞生长,并导致 miR-143、miR-145 和 miR-101 的上调。
Ann Hematol. 2014 Jun;93(6):983-93. doi: 10.1007/s00277-014-2021-4. Epub 2014 Feb 28.
10
TGFβ1 enhances MAD1 expression and stimulates promoter-bound Pol II phosphorylation: basic functions of C/EBP, SP and SMAD3 transcription factors.TGFβ1 增强 MAD1 表达并刺激启动子结合的 Pol II 磷酸化:C/EBP、SP 和 SMAD3 转录因子的基本功能。
BMC Mol Biol. 2011 Feb 23;12:9. doi: 10.1186/1471-2199-12-9.

引用本文的文献

1
Resveratrol: Targeting Cancer Stem Cells and ncRNAs to Overcome Cancer Drug Resistance.白藜芦醇:通过靶向肿瘤干细胞和非编码 RNA 克服癌症耐药性。
Curr Mol Med. 2024;24(8):951-961. doi: 10.2174/1566524023666230817102114.
2
Contribution of Non-Coding RNAs to Anticancer Effects of Dietary Polyphenols: Chlorogenic Acid, Curcumin, Epigallocatechin-3-Gallate, Genistein, Quercetin and Resveratrol.非编码RNA在膳食多酚抗癌作用中的贡献:绿原酸、姜黄素、表没食子儿茶素-3-没食子酸酯、染料木黄酮、槲皮素和白藜芦醇。
Antioxidants (Basel). 2022 Nov 28;11(12):2352. doi: 10.3390/antiox11122352.
3
Anti-Cancer Effects of Dietary Polyphenols via ROS-Mediated Pathway with Their Modulation of MicroRNAs.

本文引用的文献

1
MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis.miR-145 可直接靶向作用于肿瘤细胞中的 p70S6K1,从而抑制肿瘤生长和血管生成。
Nucleic Acids Res. 2012 Jan;40(2):761-74. doi: 10.1093/nar/gkr730. Epub 2011 Sep 14.
2
MicroRNA-145 regulates chondrogenic differentiation of mesenchymal stem cells by targeting Sox9.MicroRNA-145 通过靶向 Sox9 调节间充质干细胞的软骨分化。
PLoS One. 2011;6(7):e21679. doi: 10.1371/journal.pone.0021679. Epub 2011 Jul 20.
3
Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway.
膳食多酚通过 ROS 介导的途径及其对 microRNAs 的调节发挥抗癌作用。
Molecules. 2022 Jun 14;27(12):3816. doi: 10.3390/molecules27123816.
4
The effect of eight weeks of moderate and high intensity aerobic training on the gene expression of Mir-145, Wnt3a and Dab2 in the heart tissue of type 2 diabetic rats.八周中等强度和高强度有氧训练对2型糖尿病大鼠心脏组织中Mir-145、Wnt3a和Dab2基因表达的影响
J Diabetes Metab Disord. 2021 Oct 16;20(2):1597-1604. doi: 10.1007/s40200-021-00909-w. eCollection 2021 Dec.
5
Polyphenol-Enriched Blueberry Preparation Controls Breast Cancer Stem Cells by Targeting FOXO1 and miR-145.多酚富集蓝莓制剂通过靶向 FOXO1 和 miR-145 来控制乳腺癌干细胞。
Molecules. 2021 Jul 17;26(14):4330. doi: 10.3390/molecules26144330.
6
Metformin Reduces NGF-Induced Tumour Promoter Effects in Epithelial Ovarian Cancer Cells.二甲双胍可降低神经生长因子诱导的上皮性卵巢癌细胞中的肿瘤促进作用。
Pharmaceuticals (Basel). 2020 Oct 16;13(10):315. doi: 10.3390/ph13100315.
7
MiR-145 in cancer therapy resistance and sensitivity: A comprehensive review.癌症治疗耐药性和敏感性中的miR-145:综述
Cancer Sci. 2020 Sep;111(9):3122-3131. doi: 10.1111/cas.14517. Epub 2020 Jul 8.
8
Resveratrol Sensitizes Colorectal Cancer Cells to Cetuximab by Connexin 43 Upregulation-Induced Akt Inhibition.白藜芦醇通过上调连接蛋白43诱导Akt抑制使结肠癌细胞对西妥昔单抗敏感。
Front Oncol. 2020 Apr 7;10:383. doi: 10.3389/fonc.2020.00383. eCollection 2020.
9
Reciprocal control of ADAM17/EGFR/Akt signaling and miR-145 drives GBM invasiveness.ADAM17/表皮生长因子受体/蛋白激酶B信号通路与微小RNA-145的相互调控驱动胶质母细胞瘤侵袭性。
J Neurooncol. 2020 Apr;147(2):327-337. doi: 10.1007/s11060-020-03453-4. Epub 2020 Mar 13.
10
Assessment of biochemical recurrence of prostate cancer (Review).前列腺癌生化复发的评估(综述)。
Int J Oncol. 2019 Dec;55(6):1194-1212. doi: 10.3892/ijo.2019.4893. Epub 2019 Oct 4.
致癌性 Ras 对 miR-143/145 簇的抑制作用启动了促肿瘤发生的正反馈通路。
Genes Dev. 2010 Dec 15;24(24):2754-9. doi: 10.1101/gad.1950610.
4
FoxOs enforce a progression checkpoint to constrain mTORC1-activated renal tumorigenesis.FoxOs 建立一个进展检查点来限制 mTORC1 激活的肾肿瘤发生。
Cancer Cell. 2010 Nov 16;18(5):472-84. doi: 10.1016/j.ccr.2010.10.019.
5
Detection of microRNAs in cultured cells and paraffin-embedded tissue specimens by in situ hybridization.通过原位杂交检测培养细胞和石蜡包埋组织标本中的微小RNA。
Methods Mol Biol. 2011;676:73-83. doi: 10.1007/978-1-60761-863-8_6.
6
The CCAAT/enhancer binding protein beta is a critical regulator of steroid-induced mitotic expansion of uterine stromal cells during decidualization.CCAAT/增强子结合蛋白β是甾体诱导的蜕膜化期间子宫基质细胞有丝分裂扩张的关键调节因子。
Endocrinology. 2010 Aug;151(8):3929-40. doi: 10.1210/en.2009-1437. Epub 2010 May 25.
7
MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1.MicroRNA-145 通过直接靶向黏蛋白 1 抑制细胞侵袭和转移。
Cancer Res. 2010 Jan 1;70(1):378-87. doi: 10.1158/0008-5472.CAN-09-2021. Epub 2009 Dec 8.
8
NFkappaB p50-CCAAT/enhancer-binding protein beta (C/EBPbeta)-mediated transcriptional repression of microRNA let-7i following microbial infection.微生物感染后 NFkappaB p50-CCAAT/增强子结合蛋白β (C/EBPβ) 介导的 microRNA let-7i 的转录抑制。
J Biol Chem. 2010 Jan 1;285(1):216-25. doi: 10.1074/jbc.M109.041640. Epub 2009 Nov 10.
9
miR-145 and miR-143 regulate smooth muscle cell fate and plasticity.微小RNA-145和微小RNA-143调控平滑肌细胞的命运和可塑性。
Nature. 2009 Aug 6;460(7256):705-10. doi: 10.1038/nature08195. Epub 2009 Jul 5.
10
The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster.叙利亚仓鼠中7,12-二甲基苯并[a]蒽诱导口腔癌发生模型中微小RNA的表达谱
J Exp Clin Cancer Res. 2009 May 13;28(1):64. doi: 10.1186/1756-9966-28-64.